Cardiometabolic Risk Factors Superior to FIB4 in Identifying Adults at Risk for NAFLD with Fibrosis

被引：0
|
作者：
Leiva, Eddison Godinez
Sharma, Anu
Kalavalapalli, Srilaxmi
Rocha, Andrea Ortiz
Saenz, Enrique Valdez
Mohseni, Yasmine
Pardo, Nathaly Cuervo
Rosenberg, Jens T.
Grajo, Joseph R.
Barb, Diana
Cusi, Kenneth
机构：
来源：
DIABETES | 2024年 / 73卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.2337/db24-1352-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1352-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco
    Tahiri, Mohamed
    Sodqi, Mustapha
    Lahdami, Fatima Ez Zahra
    Marih, Latifa
    Lamdini, Hassan
    Hliwa, Wafaa
    Lahcen, Ahd Oulad
    Badre, Wafaa
    Haddad, Fouad
    Chakib, Abdelfetah
    Bellabah, Ahmed
    Alaoui, Rhimou
    El Filali, Kamal Marhoum
    WORLD JOURNAL OF HEPATOLOGY, 2013, 5 (10) : 584 - 588
  • [2] Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco
    Mohamed Tahiri
    Mustapha Sodqi
    Fatima Ez Zahra Lahdami
    Latifa Marih
    Hassan Lamdini
    Wafaa Hliwa
    Ahd Oulad Lahcen
    Wafaa Badre
    Fouad Haddad
    Abdelfetah Chakib
    Ahmed Bellabah
    Rhimou Alaoui
    Kamal Marhoum El Filali
    World Journal of Hepatology, 2013, (10) : 584 - 588
  • [3] NAFLD and Cardiometabolic Risk Factors: The Liver Fibrosis Trajectory Through the Lens of Biological Interactions
    Pirola, Carlos J.
    Sookoian, Silvia
    HEPATOLOGY, 2021, 73 (02) : 479 - 482
  • [4] The use of age-specific cutoffs for FIB4 and NAFLD Fibrosis Score in a primary care setting finds over one-third of older diabetic patients are at high risk for NAFLD with advanced fibrosis
    Islam, Kendall
    Brandman, Danielle
    Chu, Janet
    Fox, Rena
    JOURNAL OF HEPATOLOGY, 2021, 75 : S558 - S558
  • [5] Screening for liver fibrosis in tertiary care using automatic calculation of FIB4 in patients at-risk of diabetes
    Canivet, Clemence M.
    Rolland, Celine
    Joubaud, Francoise
    Genevieve, Franck
    Gervais, Stephane
    Oberti, Frederic
    Prunier, Delphine
    Moal, Valerie
    Michalak, Sophie
    Fouchard, Isabelle
    Lannes, Adrien
    Boursier, Jerome
    JOURNAL OF HEPATOLOGY, 2024, 80 : S519 - S519
  • [6] Ability of a Combined FIB4/miRNA181a Score to Predict Significant Liver Fibrosis in NAFLD Patients
    Lima, Rodrigo Vieira Costa
    Stefano, Jose Tadeu
    Malta, Fernanda de Mello
    Pinho, Joao Renato Rebello
    Carrilho, Flair Jose
    Arrese, Marco
    Oliveira, Claudia P.
    BIOMEDICINES, 2021, 9 (12)
  • [7] The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients
    Abdel-Hameed, Enass A.
    Rouster, Susan D.
    Kottilil, Shyam
    Sherman, Kenneth E.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (03) : 450 - 459
  • [8] Individuals with cardiometabolic risk factors are at higher risk for early-onset NAFLD
    He, Linfeng
    Zheng, Wenbin
    Liao, Yunfei
    Kong, Wen
    Zeng, Tianshu
    JOURNAL OF HEPATOLOGY, 2024, 81 (03) : e99 - e101
  • [9] YPrevalence and Risk Factors of NAFLD, High-Risk NASH, and Fibrosis Among Lean US Adults
    Kalligeros, Markos
    Vassilopoulos, Stephanos
    Vassilopoulos, Athanasios
    Shehadeh, Fadi
    Lazaridou, Ingrid
    Mylonakis, Eleftherios
    Promrat, Kittichai
    Wands, Jack R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1055 - S1056
  • [10] VALIDATION OF A CLINICAL CARE PATHWAY TO RISK STRATIFY PATIENTS WITH NAFLD AND COMPARING FIB4 SCORING WITH OTHER NON- INVASIVE TESTING
    Kundu, Ria Ghose
    Rangan, Pooja
    Faulkner, Claire
    Aboona, Majd
    Grade, Dylan
    Sharma, Rahul
    Dolasa-Sahani, Vir
    Shaik, Naina
    Shaik, Rayna
    Nadeem, Rida
    Wijarnpreecha, Karn
    Alkhouri, Naim
    HEPATOLOGY, 2023, 78 : S899 - S902
12345